Trejo Gutiérrez JF

Idioma: Español
Referencias bibliográficas: 19
Paginas: 267-270
Archivo PDF: 50.30 Kb.

RESUMEN

La mortalidad por cardiopatía isquémica en México se ha incrementado en las últimas décadas y demanda un análisis de sus causas, así como el planteamiento de medidas para contener y revertir tal tendencia. El incremento en el sobrepeso y obesidad, así como la diabetes mellitus señalan al síndrome metabólico como un estado patogénico intermediario para tal situación.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Lozano-Ascencio R, Escamilla-Cejudo JA, Escobedo-de la Peña J, López-Cervantes M: Tendencia de la mortalidad por cardiopatía isquémica en México de 1950 a 1985. Salud Pública Mex 1990; 32: 405-415.

2. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.

3. Han TS, Williams K, Sattar N, Hunt KJ, Lean MEJ, Haffner SM: Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002; 10: 923-931.

4. Hanley AJG, Karter AJ, Festa A, D’Agostino R, Wagenknecht LE, Savage P, et al: Factor analysis of metabolic syndrome using directly measured insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 2642-47.

5. Neel JV: Diabetes mellitus: a thrifty genotype rendered detrimental by “progress”? Am J Hum Genetics 1962; 14: 353-362.

6. Bjorntorp P, Rosmond R: The Metabolic syndrome- a neuroendocrine disorder? B J Nutrition 2000; 83(Suppl. 1): S49-S57.

7. Chrousos GP: The roles of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int J Obesity 2000; 24(Suppl. 2): S50-S55.

8. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, et al: Adrenocortical, autonomic and inflammatory causes of the metabolic syndrome. Nested Case-Control Study. Circulation 2002; 106: 2659-65.

9. Kreier F, Fliers E, Voshol PJ, et al: Selective parasympathetic innervation of subcutaneous and intra-abdominal fat-functional implications. J Clin Invest 2002; 110: 1243-50.

10. Boden G, Hoeldtke RD: Nerves, Fat and Insulin Resistance. N Engl J Med 2003; 349: 1966-67.

11. Boule NG, Tremblay A, Gonzalez-Barranco J, Aguilar-Salinas CA, Lopez-Alvarenga JC, Despres JP, et al. Insulin resistance and abdominal adiposity in young men with documented malnutrition during the first year of life. Int J Obesity 2003; 27: 598-604.

12. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.

13. National Cholesterol Education Program: Executive Summary of the third report of the National cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.

14. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 2002: 287: 356-359.

15. Alexander CM, Landsman PB, Teutsch SM, et al: NCEP-defined metabolic syndrome, diabetes mellitus and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214.

16. Velásquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Grupo ENSA 2000, Attie F, Tapia-Conyer R: Hipertensión Arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2002; 72: 71-84.

17. Encuesta Nacional de Enfermedades Crónicas: Epidemiología SSA 1993.

18. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean MEJ, Haffner SM: Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-21.

19. Escobedo-de la Peña J, Escamilla-Cejudo JA, Santos-Burgos C: Colesterol sérico y diabetes mellitus: Principales factores de riesgo independientes en la mortalidad por cardiopatía isquémica en México. Arch Inst Cardiol Mex 1994; 64: 189-195.